These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25109632)

  • 1. γEpithelial Na(+) Channel (γENaC) and the Acid-Sensing Ion Channel 1 (ASIC1) expression in the urothelium of patients with neurogenic detrusor overactivity.
    Traini C; Del Popolo G; Lazzeri M; Mazzaferro K; Nelli F; Calosi L; Vannucchi MG
    BJU Int; 2015 Nov; 116(5):797-804. PubMed ID: 25109632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration.
    Datta SN; Roosen A; Pullen A; Popat R; Rosenbaum TP; Elneil S; Dasgupta P; Fowler CJ; Apostolidis A
    J Urol; 2010 Dec; 184(6):2578-85. PubMed ID: 21030043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
    Brady CM; Apostolidis AN; Harper M; Yiangou Y; Beckett A; Jacques TS; Freeman A; Scaravilli F; Fowler CJ; Anand P
    BJU Int; 2004 Apr; 93(6):770-6. PubMed ID: 15049988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
    Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P
    Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
    Chen SF; Chang CH; Kuo HC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.
    Ballouhey Q; Panicker JN; Mazerolles C; Roumiguie M; Zaidi F; Rischmann P; Malavaud B; Game X
    Int Braz J Urol; 2015; 41(6):1141-7. PubMed ID: 26742972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive changes of telocytes in the urinary bladder of patients affected by neurogenic detrusor overactivity.
    Traini C; Fausssone-Pellegrini MS; Guasti D; Del Popolo G; Frizzi J; Serni S; Vannucchi MG
    J Cell Mol Med; 2018 Jan; 22(1):195-206. PubMed ID: 28782880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
    Radziszewski P; Crayton R; Zaborski J; Członkowska A; Borkowski A; Bossowska A; Majewski M
    Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Roosen A; Datta SN; Chowdhury RA; Patel PM; Kalsi V; Elneil S; Dasgupta P; Kessler TM; Khan S; Panicker J; Fry CH; Brandner S; Fowler CJ; Apostolidis A
    Eur Urol; 2009 Jun; 55(6):1440-8. PubMed ID: 19054608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics.
    Álvares RA; Araújo ID; Sanches MD
    BMC Urol; 2014 Aug; 14():66. PubMed ID: 25123234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve sprouting and neurogenic inflammation characterize the neurogenic detrusor overactive bladder of patients no longer responsive to drug therapies.
    Traini C; Del Popolo G; Faussone-Pellegrini MS; Guasti D; Catarinicchia S; Vannucchi MG
    J Cell Mol Med; 2019 Jun; 23(6):4076-4087. PubMed ID: 30945429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Apostolidis A; Jacques TS; Freeman A; Kalsi V; Popat R; Gonzales G; Datta SN; Ghazi-Noori S; Elneil S; Dasgupta P; Fowler CJ
    Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.
    Popat R; Apostolidis A; Kalsi V; Gonzales G; Fowler CJ; Dasgupta P
    J Urol; 2005 Sep; 174(3):984-9. PubMed ID: 16094019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patients.
    Oger S; Behr-Roussel D; Gorny D; Bernabé J; Comperat E; Chartier-Kastler E; Denys P; Giuliano F
    BJU Int; 2011 Aug; 108(4):604-11. PubMed ID: 21166758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury.
    Chen SF; Jiang YH; Kuo HC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):125-133. PubMed ID: 29482913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and response of acid-sensing ion channels in urinary bladder to cyclophosphamide-induced cystitis.
    Corrow K; Girard BM; Vizzard MA
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1130-9. PubMed ID: 20164155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder.
    Phé V; Behr-Roussel D; Oger-Roussel S; Rouprêt M; Chartier-Kastler E; Lebret T; Karsenty G; Compérat E; Camparo P; Giuliano F
    Urology; 2013 May; 81(5):1108.e1-6. PubMed ID: 23490518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels.
    Hristov KL; Afeli SA; Parajuli SP; Cheng Q; Rovner ES; Petkov GV
    PLoS One; 2013; 8(7):e68052. PubMed ID: 23861849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction.
    Yokokawa R; Akino H; Ito H; Zha X; Yokoyama O
    Neurourol Urodyn; 2017 Aug; 36(6):1448-1455. PubMed ID: 27676696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.
    Roosen A; Apostolidis A; Elneil S; Khan S; Panicker J; Brandner S; Fowler CJ; Kessler TM
    J Urol; 2009 Jul; 182(1):190-5. PubMed ID: 19450843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.